IMTX peer analysis
Immatics (IMTX) against its competitors: price, today's move, 1-year return and market value side by side.
IMTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALLO Allogene Therapeutics | $0.75 | -7.06% | -39.46% | $258.01M |
| ATRA Atara Biotherapeutics | $6.40 | -16.88% | -53.49% | $65.21M |
| BNTX BioNTech | $84.86 | -0.47% | -17.74% | $21.02B |
| CLLS Cellectis | $1.04 | -11.86% | -73.33% | $104.76M |
| DTIL Precision BioSciences | $7.05 | -3.16% | 19.73% | $196.67M |
| IMCR Immunocore | $27.81 | -3.70% | -22.64% | $1.44B |
| JANX Janux | $10.78 | -1.28% | -63.41% | $655.58M |
| LEGN Legend Biotech | $16.35 | 2.25% | -46.81% | $2.98B |
| LYEL Lyell Immunopharma | $13.66 | -6.76% | -19.37% | $335.59M |
| TCRX TScan Therapeutics | $0.15 | -9.65% | -86.81% | $9.83M |
| IMTX Immatics | $6.41 | 3.89% | -38.24% | $942.71M |
- IMTX's peers: ALLO (Allogene Therapeutics), ATRA (Atara Biotherapeutics), BNTX (BioNTech), CLLS (Cellectis), DTIL (Precision BioSciences), IMCR (Immunocore), JANX (Janux), LEGN (Legend Biotech).
Updated 2026-11-18 05:48 UTC